Floatz logo

6 assets in Pemphigus Vulgaris

Therapeutic assets addressing Pemphigus Vulgaris, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Jnj-78436735
Pemphigus Vulgaris
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Moderna Covid-19 Vaccine Rna
Pemphigus Vulgaris
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Monovalent [B.1.351] Cov2 Pres Dtm-As03
Pemphigus Vulgaris
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (53)
Methotrexate
Pemphigus Vulgaris
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (52)
Tozinameran
Pemphigus Vulgaris
National Institute of Allergy and Infectious Diseases (NIAID)P2CCC (50)
bnt162b2
Pemphigus Vulgaris
National Institute of Allergy and Infectious Diseases (NIAID)P2CC (43)